193 related articles for article (PubMed ID: 18645709)
41. The T/C polymorphism of the CYP17 gene and G/A polymorphism of the CYP19 gene in endometrial cancer.
Szyllo K; Smolarz B; Romanowicz-Makowska H; Lewy J; Kulig B
J Exp Clin Cancer Res; 2006 Sep; 25(3):411-6. PubMed ID: 17167982
[TBL] [Abstract][Full Text] [Related]
42. [Association between polymorphisms of CYP17 and CYP3A4 genes and intrahepatic cholestasis of pregnancy in Chengdu].
Zhang L; Liu SY; Chen Q; Shi QY; Zou H; Wu L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):551-3, 582. PubMed ID: 16909599
[TBL] [Abstract][Full Text] [Related]
43. CYP17 and SULT1A1 gene polymorphisms in Indian breast cancer.
Chacko P; Rajan B; Mathew BS; Joseph T; Pillai MR
Breast Cancer; 2004; 11(4):380-8. PubMed ID: 15604994
[TBL] [Abstract][Full Text] [Related]
44. The CYP17 and CYP19 gene single nucleotide polymorphism in women with sporadic breast cancer.
Sobczuk A; Romanowicz H; Fiks T; Połać I; Smolarz B
Pol J Pathol; 2009; 60(4):163-7. PubMed ID: 20072949
[TBL] [Abstract][Full Text] [Related]
45. Cyp17 genetic polymorphism in prostate cancer and benign prostatic hyperplasia.
Tigli H; Yazici H; Dalay N
Res Commun Mol Pathol Pharmacol; 2003; 113-114():307-14. PubMed ID: 15686129
[TBL] [Abstract][Full Text] [Related]
46. Tumor necrosis factor-alpha-308 promoter and p53 codon 72 gene polymorphisms in women with leiomyomas.
Hsieh YY; Chang CC; Tsai FJ; Lin CC; Yeh LS; Tsai CH
Fertil Steril; 2004 Oct; 82 Suppl 3():1177-81. PubMed ID: 15474092
[TBL] [Abstract][Full Text] [Related]
47. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
Ye Z; Parry JM
Mutagenesis; 2002 Mar; 17(2):119-26. PubMed ID: 11880540
[TBL] [Abstract][Full Text] [Related]
48. A polymorphism in the CYP17 gene relates to the risk of recurrent pregnancy loss.
Sata F; Yamada H; Yamada A; Kato EH; Kataoka S; Saijo Y; Kondo T; Tamaki J; Minakami H; Kishi R
Mol Hum Reprod; 2003 Nov; 9(11):725-8. PubMed ID: 14561815
[TBL] [Abstract][Full Text] [Related]
49. Polymorphisms in genes HSD17B1 and HSD17B2 and uterine leiomyoma risk in Chinese women.
Cong RJ; Huang ZY; Cong L; Ye Y; Wang Z; Zha L; Cao LP; Su XW; Yan J; Li YB
Arch Gynecol Obstet; 2012 Sep; 286(3):701-5. PubMed ID: 22546946
[TBL] [Abstract][Full Text] [Related]
50. A CYP17A1 gene polymorphism in association with multiple uterine leimyomas; a meta-analysis.
Pakiz M; Potocnik U; But I; Mujezinovic F
Cancer Biomark; 2010-2011; 8(1):29-34. PubMed ID: 21896988
[TBL] [Abstract][Full Text] [Related]
51. Association of a CYP17 gene polymorphism with development of breast cancer in India.
Surekha D; Sailaja K; Rao DN; Padma T; Raghunadharao D; Vishnupriya S
Asian Pac J Cancer Prev; 2010; 11(6):1653-7. PubMed ID: 21338212
[TBL] [Abstract][Full Text] [Related]
52. G-protein-coupled estrogen receptor-30 gene polymorphisms are associated with uterine leiomyoma risk.
Kasap B; Öztürk Turhan N; Edgünlü T; Duran M; Akbaba E; Öner G
Bosn J Basic Med Sci; 2016 Jan; 16(1):39-45. PubMed ID: 26773178
[TBL] [Abstract][Full Text] [Related]
53. Cytochrome P450c17alpha gene (CYP17) polymorphism predicts use of hormone replacement therapy.
Feigelson HS; McKean-Cowdin R; Pike MC; Coetzee GA; Kolonel LN; Nomura AM; Le Marchand L; Henderson BE
Cancer Res; 1999 Aug; 59(16):3908-10. PubMed ID: 10463580
[TBL] [Abstract][Full Text] [Related]
54. Association of Cytochrome-17 (MspA1) Gene Polymorphism with Risk of Gall Bladder Stones and Cancer in North India.
Dwivedi S; Agrawal S; Singh S; Madeshiya AK; Singh D; Mahdi AA; Chandra A
Asian Pac J Cancer Prev; 2015; 16(13):5557-63. PubMed ID: 26225710
[TBL] [Abstract][Full Text] [Related]
55. CYP17 gene promoter allelic variant is not associated with prostate cancer.
Lin CC; Wu HC; Chen WC; Chen HY; Tsai FJ
Urol Oncol; 2003; 21(4):262-5. PubMed ID: 12954495
[TBL] [Abstract][Full Text] [Related]
56. CYP17 polymorphism and hot flushes in postmenopausal women.
Massad-Costa AM; Nogueira-de-Souza NC; de Carvalho CV; da Silva ID; Guindalini C; Nogueira RC; Soares JM; Haidar MA; Baracat EC
Climacteric; 2008 Oct; 11(5):404-8. PubMed ID: 18781485
[TBL] [Abstract][Full Text] [Related]
57. The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.
Allen NE; Forrest MS; Key TJ
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):185-9. PubMed ID: 11303586
[TBL] [Abstract][Full Text] [Related]
58. [Study on the relationship between polymorphisms of genes (CYP17, CYP19 and SULT1A1) and susceptibility to breast cancer in Chinese women].
Hu MB; Xie W; Xiong B; Han DF; Li Y; Feng MH; Zhou YF
Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Apr; 27(4):351-5. PubMed ID: 16875543
[TBL] [Abstract][Full Text] [Related]
59. Leu/Val SNP polymorphism of CYP1B1 and risk of uterine leiomyoma in a Black population.
Bideau VS; Alleyne AT
Tumour Biol; 2016 Mar; 37(3):4035-40. PubMed ID: 26482777
[TBL] [Abstract][Full Text] [Related]
60. Genetic polymorphisms of steroid hormone metabolizing enzymes and risk of liver cancer in hepatitis C-infected patients.
Rossi L; Leveri M; Gritti C; De Silvestri A; Zavaglia C; Sonzogni L; Silvestri L; Civardi E; Mondelli MU; Silini EM
J Hepatol; 2003 Oct; 39(4):564-70. PubMed ID: 12971967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
